Skip to content
10-Q

Quarterly Report

Rocket Pharmaceuticals, Inc. RCKT RCKTW

0000950170-25-104996

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 107.9M sh
Shares Diluted Q2 2025 · Jun 30, 2025 111.02M sh
Shares Diluted Q2 2025 · Jun 30, 2025 110.56M sh
Shares Diluted Q2 2025 · Jun 30, 2024 93.75M sh
Shares Diluted Q2 2025 · Jun 30, 2024 93.76M sh
Capex Q2 2025 · Jun 30, 2025 $414K
Capex Q2 2025 · Jun 30, 2024 $3.97M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$104.75M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$110.68M
Short Term Investments Q2 2025 · Jun 30, 2025 $238.68M
Short Term Investments Q2 2025 · Dec 31, 2024 $208.7M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $32.82M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $163.64M
Stockholders Equity Q2 2025 · Jun 30, 2025 $354.21M
Stockholders Equity Q2 2025 · Mar 31, 2025 $412.14M
Stockholders Equity Q2 2025 · Dec 31, 2024 $463.23M
Stockholders Equity Q2 2025 · Jun 30, 2024 $384.64M
Stockholders Equity Q2 2025 · Mar 31, 2024 $441.5M
Stockholders Equity Q2 2025 · Dec 31, 2023 $492.57M
Current Liabilities Q2 2025 · Jun 30, 2025 $43.4M
Current Liabilities Q2 2025 · Dec 31, 2024 $40.68M
Total Liabilities Q2 2025 · Jun 30, 2025 $66.77M
Total Liabilities Q2 2025 · Dec 31, 2024 $64.47M
Current Assets Q2 2025 · Jun 30, 2025 $277.16M
Current Assets Q2 2025 · Dec 31, 2024 $378.18M
Total Assets Q2 2025 · Jun 30, 2025 $420.98M
Total Assets Q2 2025 · Dec 31, 2024 $527.7M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.62
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.18
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.74
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.40
Eps Basic Q2 2025 · Jun 30, 2025 −$0.62
Eps Basic Q2 2025 · Jun 30, 2025 −$1.18
Eps Basic Q2 2025 · Jun 30, 2024 −$0.74
Eps Basic Q2 2025 · Jun 30, 2024 −$1.40
Sga Expense Q2 2025 · Jun 30, 2025 $25.02M
Sga Expense Q2 2025 · Jun 30, 2025 $53.47M
Sga Expense Q2 2025 · Jun 30, 2024 $27.37M
Sga Expense Q2 2025 · Jun 30, 2024 $49.52M
Rd Expense Q2 2025 · Jun 30, 2025 $42.66M
Rd Expense Q2 2025 · Jun 30, 2025 $78.6M
Rd Expense Q2 2025 · Jun 30, 2024 $46.35M
Rd Expense Q2 2025 · Jun 30, 2024 $91.57M
Net Income Q2 2025 · Jun 30, 2025 −$68.92M
Net Income Q2 2025 · Jun 30, 2025 −$130.25M
Net Income Q2 2025 · Mar 31, 2025 −$61.33M
Net Income Q2 2025 · Jun 30, 2024 −$69.65M
Net Income Q2 2025 · Jun 30, 2024 −$131.7M
Net Income Q2 2025 · Mar 31, 2024 −$62.05M
Operating Income Q2 2025 · Jun 30, 2025 −$71.15M
Operating Income Q2 2025 · Jun 30, 2025 −$135.54M
Operating Income Q2 2025 · Jun 30, 2024 −$73.71M
Operating Income Q2 2025 · Jun 30, 2024 −$141.09M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $0